Torrent Pharma’s shares surged over 3% in morning trades following the company’s robust Q3 results for the financial year. As of 9:55 AM, the shares were trading 3.21% higher at Rs 3,352.75.
The pharmaceutical giant reported a 14% year-on-year rise in net profit, amounting to ₹503 crore for the October-December quarter, compared to ₹443 crore during the same period in the previous year.
Revenue from operations saw a modest increase of 2.6%, reaching ₹2,762 crore in Q3 FY2025, up from ₹2,691 crore in Q3 FY2024. Despite global economic pressures, Torrent Pharma has managed to maintain steady growth in its operations.
The company also successfully reduced its total expenses by 0.23%, bringing them down to ₹2,151 crore from ₹2,156 crore year-on-year. This reflects the company’s effective cost management strategies during the quarter.
In a positive move for shareholders, Torrent Pharma declared an interim dividend of ₹26 per equity share of ₹5, which amounts to 520%. This dividend is expected to be paid on or around February 17, 2025.
Torrent Pharmaceuticals’ stock opened at ₹3,250.00, reaching a high of ₹3,360.70 and a low of ₹3,250.00 on the day. Over the past year, the stock has fluctuated between a 52-week high of ₹3,590.70 and a low of ₹2,414.00, highlighting its price volatility.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
